Enter your email below and get the coupon code directly in your inbox.
Need help booking an appointment? Call or text us at 437-826-1959 or email us at patientcare@wellnesshaus.com
.webp)
(semaglutide) injection
Weekly injection
Helps you feel full faster, longer
Lose 15% of your body weight on average in 1 year
Health Canada approved for weight loss
Step 01
Step 02
Step 03
Step 04
Eligibility Criteria
You must be at least 18 years of age to enroll in our Medical Weight Loss Program.
You must have a Body Mass Index (BMI) of 21 or higher.
Individuals with Type 1 diabetes are not eligible to participate in this program due to specific medical considerations associated with their condition.
*If we determine after the initial consultation that we're unable to treat you or enroll you into our program, you will receive a full refund. Please note that medication costs are not included.
Meet our expert
Best-Selling Author and Weight Loss Expert
Dr. Melissa Hershberg, MD, is a board-certified physician, best-selling author and weight loss expert. Through her books, weight loss programs, articles and speaking, she has helped thousands of people make positive lifestyle changes.
Important Safety Information
Wegovy is Health Canada approved for weight loss. Wegovy may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2.
.webp)
What is Wegovy?
Wegovy is a brand-name version of the generic medication semaglutide, which is a type of medication called a glucagon-like peptide 1 receptor agonist. Instead of that tongue-twister of a name, we call these medications “GLP-1s” for short. Wegovy is Health Canada approved and clinically proven to help with weight loss. How? It acts like a natural hormone your body uses to regulate blood sugar and appetite—key steps in resetting your biological set point to help you maintain a new, lower weight. In fact, in the pivotal clinical trial people who combined Wegovy with lifestyle changes lost an average of 9% of their body weight after 20 weeks, and 14.9% after 68 weeks.
How Does Wegovy Work?
Wegovy works by mimicking the hormone GLP-1, which slows digestion and helps your brain regulate appetite by reducing hunger sensations. As your digestion slows, you may feel full longer and therefore eat less, which can lead to weight loss.
How Do You Take Wegovy?
Wegovy comes in a prefilled injection pen. If prescribed, you (or someone in your household) will administer the injection under the skin of your stomach, thigh, or arm once a week. While a routine injection may sound intimidating, the Wegovy pen uses a tiny needle designed to minimize discomfort. You’ll also receive clear instructions on using the injection pen, and your Medical Weight Loss Team can offer additional advice.
How Quickly Do People Lose Weight with Wegovy?
In the STEP 4 clinical trial, people who combined Wegovy with a healthy diet and exercise lost an average of over 4% of their body weight by eight weeks. Those who reached a steady dose of 2.4 mg per week lost an average of 10.6% of their body weight in the first 20 weeks of treatment—and over 17% of their body weight within 68 weeks. Everyone responds to Wegovy differently, and if prescribed, your Medical Weight Loss Team will work with you to get the best results for you.
Side Effects
Wegovy® may cause serious side effects, including:
Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
.webp)
